Daniel C. Chambers
About
Daniel C. Chambers is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology.
According to data from OpenAlex, Daniel C. Chambers has authored 178 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Surgery, 76 papers in Pulmonary and Respiratory Medicine and 35 papers in Epidemiology. Recurrent topics in Daniel C. Chambers's work include Transplantation: Methods and Outcomes (84 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (41 papers) and Organ Transplantation Techniques and Outcomes (27 papers). Daniel C. Chambers is often cited by papers focused on Transplantation: Methods and Outcomes (84 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (41 papers) and Organ Transplantation Techniques and Outcomes (27 papers). Daniel C. Chambers collaborates with scholars based in Australia, United States and United Kingdom. Daniel C. Chambers's co-authors include Josef Stehlik, Wida S. Cherikh, Kiran K. Khush, Bruno Meiser, Joseph W. Rossano, Don Hayes, Bronwyn Levvey, Anna Y. Kucheryavaya, Samuel Goldfarb and Michael O. Harhay and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
In The Last Decade
Daniel C. Chambers
170 papers receiving 8.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Daniel C. Chambers Australia | 40 | 6.1k | 2.6k | 2.1k | 2.0k | 1.2k | 178 | 8.9k | ||
| Christian Benden Switzerland | 36 | 6.5k 1.1× | 2.4k 0.9× | 2.3k 1.1× | 2.2k 1.1× | 1.4k 1.1× | 196 | 8.5k | ||
| John H. Dark United Kingdom | 45 | 5.6k 0.9× | 2.4k 0.9× | 1.4k 0.7× | 1.5k 0.7× | 981 0.8× | 278 | 7.7k | ||
| L.G. Singer Canada | 52 | 6.8k 1.1× | 4.0k 1.6× | 2.3k 1.1× | 1.5k 0.7× | 2.1k 1.7× | 282 | 9.9k | ||
| Allan R. Glanville Australia | 44 | 5.4k 0.9× | 3.5k 1.4× | 1.9k 0.9× | 897 0.4× | 1.9k 1.6× | 203 | 8.1k | ||
| Bronwyn Levvey Australia | 40 | 7.3k 1.2× | 1.7k 0.6× | 2.8k 1.3× | 2.4k 1.2× | 1.3k 1.1× | 167 | 8.6k | ||
| J. Wallwork United Kingdom | 50 | 6.2k 1.0× | 3.0k 1.2× | 1.6k 0.7× | 1.1k 0.5× | 1.5k 1.2× | 296 | 9.5k | ||
| Bruno Meiser Germany | 48 | 9.2k 1.5× | 1.7k 0.7× | 4.1k 1.9× | 3.2k 1.6× | 1.5k 1.2× | 175 | 11.6k | ||
| A. Ardehali United States | 45 | 3.6k 0.6× | 1.4k 0.5× | 1.2k 0.5× | 1.1k 0.5× | 957 0.8× | 226 | 5.9k | ||
| Anna Y. Kucheryavaya United States | 46 | 10.1k 1.7× | 2.3k 0.9× | 3.9k 1.8× | 3.8k 1.9× | 1.5k 1.3× | 63 | 12.2k | ||
| Marc de Perrot Canada | 63 | 7.6k 1.2× | 7.0k 2.7× | 1.6k 0.7× | 2.6k 1.3× | 689 0.6× | 403 | 14.9k |
Countries citing papers authored by Daniel C. Chambers
Since
Specialization
Citations
This map shows the geographic impact of Daniel C. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Chambers more than expected).
Fields of papers citing papers by Daniel C. Chambers
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Daniel C. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Chambers. The network helps show where Daniel C. Chambers may publish in the future.
Co-authorship network of co-authors of Daniel C. Chambers
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. Chambers. A scholar is included among the top collaborators of Daniel C. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. Chambers. Daniel C. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mackintosh, John A., Gregory J. Keir, Lauren Troy, et al.. (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 29(2). 105–135.
2.
Luong, Me‐Linh, Fernanda P. Silveira, C. Orla Morrissey, et al.. (2024). Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel. Transplant Infectious Disease. 26(3). e14251–e14251.
3.
Smith, Daniel J., et al.. (2024). Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing. Frontiers in Cellular and Infection Microbiology. 14. 1426773–1426773.
4.
Harhay, Michael O., Wida S. Cherikh, Alice E. Toll, et al.. (2022). Epidemiology, risk factors, and outcomes of lung retransplantation: An analysis of the International Society for Heart and Lung Transplantation Thoracic Transplant Registry. The Journal of Heart and Lung Transplantation. 41(10). 1478–1486.
5.
Pandeya, Nirmala, Nancy Ν. Huang, Elsemieke I. Plasmeijer, et al.. (2022). Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic study. Archives of Dermatological Research. 315(4). 771–777.
6.
Hayes, Don, Michael O. Harhay, Wida S. Cherikh, et al.. (2021). The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric lung transplantation report — 2021; Focus on recipient characteristics. The Journal of Heart and Lung Transplantation. 40(10). 1023–1034.
7.
Holland, Anne E., Tamera J. Corte, Daniel C. Chambers, et al.. (2020). Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trial. BMJ Open. 10(12). e040798–e040798.
8.
Dummer, Jack, Claudia C. Dobler, Mark Holmes, et al.. (2020). Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand*. Respirology. 25(3). 321–335.
9.
Ogger, Patricia P., Richard Hewitt, Brendan O’Sullivan, et al.. (2020). Itaconate controls the severity of pulmonary fibrosis. Science Immunology. 5(52).
10.
Hayes, Don, Michael O. Harhay, Wida S. Cherikh, et al.. (2020). The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-third pediatric lung transplantation report — 2020; focus on deceased donor characteristics. The Journal of Heart and Lung Transplantation. 39(10). 1038–1049.
11.
Way, Mandy, Louise Marquart, Daniel C. Chambers, et al.. (2019). Skin cancer multiplicity in lung transplant recipients: a prospective population‐based study. British Journal of Dermatology. 183(3). 503–508.
12.
Yerkovich, Stephanie T., Fuming Zhang, Xinyue Liu, et al.. (2018). Endothelial Glycocalyx Shedding Predicts Donor Organ Acceptability and Is Associated With Primary Graft Dysfunction in Lung Transplant Recipients. Transplantation. 103(6). 1277–1285.
13.
Chambers, Daniel C., Wida S. Cherikh, Samuel Goldfarb, et al.. (2018). The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report—2018; Focus theme: Multiorgan Transplantation. The Journal of Heart and Lung Transplantation. 37(10). 1169–1183.
14.
Chambers, Daniel C., et al.. (2015). Physical Activity Level - a New Marker of Frailty in Lung Transplantation. Respirology. 20. 20–20.
15.
Holmes‐Liew, Chien‐Li, Leone Beagley, Philip Hopkins, et al.. (2015). Adoptive T-Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cmv Disease After Lung Transplantation. Respirology. 20. 117–117.
16.
Willner, Dana, Philip Hugenholtz, Stephanie T. Yerkovich, et al.. (2013). Reestablishment of Recipient-associated Microbiota in the Lung Allograft Is Linked to Reduced Risk of Bronchiolitis Obliterans Syndrome. American Journal of Respiratory and Critical Care Medicine. 187(6). 640–647.
17.
Bilton, Diana, Gregory Tino, Alan R. Barker, et al.. (2013). Inhaled mannitol for non-cystic fibrosis bronchiectasis - results of a 12 month, multi-centre, double-blind, controlled study. European Respiratory Journal. 42(Suppl 57). 1966–1966.
18.
Yerkovich, Stephanie T., et al.. (2013). Hypogammaglobulinaemia Post-Lung Transplant Is Associated with Deficent B Cell Function. Queensland's institutional digital repository (The University of Queensland).
19.
Ng, Benjamin, Allan R. Glanville, G. Snell, et al.. (2011). The Impact of Pandemic Influenza A H1N1 2009 on Australian Lung Transplant Recipients. American Journal of Transplantation. 11(3). 568–574.
20.
Chambers, Daniel C., et al.. (1977). Studies on a rat liver subcellular poly A-rich RNA fraction with glutamate dehydrogenase template activity.. PubMed. 9(3). 205–15.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Christian Benden Breakdown of academic impact, for papers by John H. Dark Breakdown of academic impact, for papers by L.G. Singer Breakdown of academic impact, for papers by Allan R. Glanville Breakdown of academic impact, for papers by Bronwyn Levvey Breakdown of academic impact, for papers by J. Wallwork Breakdown of academic impact, for papers by Bruno Meiser Breakdown of academic impact, for papers by A. Ardehali Breakdown of academic impact, for papers by Anna Y. Kucheryavaya Breakdown of academic impact, for papers by Marc de Perrot